Peptide News Digest

#Lasso-Peptides

2 stories

Research · View digest

Princeton Chemists Attach a Cell-Penetrating Peptide to Lasso Peptide Antibiotics, Extending Them to All Four Gram-Negative ESKAPE Pathogens

Princeton University chemists reported in ACS Chemical Biology on October 27, 2026 that conjugating a cell-penetrating peptide to the loop of the lasso peptides citrocin and microcin J25, which kill bacteria by blocking RNA polymerase but depend on specific transporters to get inside, gave them activity against all four Gram-negative ESKAPE pathogens. The conjugates were more potent than the parent peptides, with minimum inhibitory concentrations from high nanomolar to single micromolar, and entered E. coli through both transporter-dependent and transporter-independent routes, which the authors say could limit one path to resistance. The work is in bacterial cultures.

Research · View digest

Aarhus Team Finds the 1967 Antibiotic Lasso Peptide Triculamin Needs an Unusual 'Follower' Tail to Be Made

Researchers at Aarhus University's Department of Biological and Chemical Engineering reported in The Journal of Antibiotics on October 26, 2026 that the follower peptide attached to triculamin's precursor, a feature unlike other lasso peptides, is essential for making the antibiotic. Structural predictions and targeted mutations suggest the follower binds the ring-closing enzyme and delivers the core peptide to its active site. The team made triculamin analogs by changing the core peptide, identified lysine-3 in the ring as the acetylation site, and found Burkholderia sp. FERM BP-3421 to be a better host for producing it.